V.8. Irodalomjegyzék

  1. Alcalai, R., J. Seidman, and C. Seidman. Genetic basis of hypertrophic cardiomyopathy: From bench to the clinics. J Cardiovasc Electrophysiol, 2008. 19: p. 104-110.
  2. Bos, J., J. Towbin, and M. Ackerman. Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy. J Am Coll Cardiol, 2009. 54: p. 201-11.
  3. Burkett, E. and R. Hershberger. Clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol, 2005. 45: p. 969-81.
  4. Hershberger, R., et al.. Progress with genetic cardiomyopathies screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Heart Fail, 2009. 2: p. 253-61.
  5. Thiene, D. Corrado, and C. Basso. Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Orphanet Journal of Rare Diseases, 2007. 2: p. 45.
  6. Kass, R. and A. Moss. Long QT syndrome: novel insights into the mechanisms of cardiac arrhythmias. J Clin Invest, 2003. 112: p. 810-5.
  7. Wehrens, X., et al. Novel insights in the congenital long QT syndrome. Ann Intern Med, 2002. 137: p. 981-92.
  8. Antzelevitch, C., et al. Brugada Syndrome. A decade of progress. Circ Res, 2002. 91: p. 1114-1118.
  9. Priori, S., et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation, 2001. 103: p. 196-200.
  10. Priori, S., et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation, 2002. 106: p. 69-74.